ELOCTATE
Marca svizra · 631752 · Marca da pled · En vigur
Inscripziun en il register
- Numer da registraziun
- 631752
- Numer da la dumonda
- 50786/2012
- Status
- En vigur
- Tip
- Marca da pled
- Deponida
- 24-01-2012
- Registrada
- 12-07-2012
- Publitgada
- 12-07-2012
- Protegida fin ils
- 24-01-2032
- Prioritad
- 31.08.2011 US
- Lingua da la procedura
- tudestg
Products e servetschs
Pharmaceuticals
Pharmazeutische Präparate für die Behandlung von Hämophilie.
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 14-12-2023
Adressa dal represchentant midada
- Representative
- E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich
Published in Swissreg on 14.12.2023
- 18-11-2021
Prolungà
Published in Swissreg on 18.11.2021
- 06-10-2016
Transferì
- Owner
- Biogen MA Inc., 250 Binney Street, Cambridge, MA 02142, USA → Swedish Orphan Biovitrum AB (Publ), 112 76 Stockholm, Sweden
Published in Swissreg on 06.10.2016
- 24-05-2016
Adressa dal possessur midada
- Owner
- Biogen Idec MA Inc., a corporation, organized under the laws of Massachusetts, USA, 14 Cambridge Center, Cambridge, MA 02142, USA → Biogen MA Inc., 250 Binney Street, Cambridge, MA 02142, USA
Published in Swissreg on 24.05.2016
- 12-07-2012
Registrà
Published in Swissreg on 12.07.2012
Partidas
Possessura
Swedish Orphan Biovitrum AB (Publ)
112 76 Stockholm, SE
Represententa
Il register numna mintga partida cun num ed adressa. Ina partida è colliada cun ina unitad, sch’exactamain ina unitad dal register da commerzi porta ses num; la via d’ina partida betg uschia renconuschida na vegn betg mussada qua.